Friday, October 6
Heart in Jeopardy: Innovations in Hypertrophic Cardiomyopathy
8:00 PM - 9:30 PM | Room 1
Provided by Medscape and supported through an independent educational grant from Cytokinetics
Saturday, October 7
Improving Outcomes with SGLT2 Inhibitors in Patients with Heart Failure: From Evidence to Clinical Practice
7:30 AM - 8:45 AM | Room 3
Provided by Voxmedia and HFSA and supported through an independent educational grant from AstraZeneca
Demystifying Diagnosis and Treatment of Iron Deficiency in Heart Failure
7:30 AM - 8:45 AM | Room 5
Provided by Medscape and supported through an independent educational grant from American Regent
Evolving Concepts for Heart Failure Treatment and Recovery at Cleveland Clinic
7:15 PM - 8:45 PM | Room 1
Provided by the Cleveland Clinic
Key Insights to Optimize the Management of HFrEF and Role of sGC Modulators
7:15 PM - 8:45 PM | Room 4
Provided by Vindico and supported through an independent educational grant from Merck & Co., Inc.
Sunday, October 8
Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Workflows to Realize the Greatest Benefit in oHCM and Beyond
7:00 AM - 8:00 AM | Room 3
Provided by Peerview and supported through an independent educational grant from Bristol Myers Squibb
The New Standard of Care: Leveraging the Benefits of SGLT2 Inhibitors Across the Heart Failure Spectrum
7:00 AM - 8:15 AM | Room 5
Provided by Clinical Care Options and HFSA and supported through an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA
Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Best Practices for Successful Outcomes in Patients with Heart Failure
5:00 PM - 6:00 PM | Room 1
Provided by Voxmedia and HFSA and supported through an independent educational grant from AstraZeneca
Striking a Balance: Managing Hyperkalemia in Heart Failure Patients with Chronic Kidney Disease
5:00 PM - 6:00 PM | Room 5
Provided by Clinical Care Options and supported through an independent educational grant from AstraZeneca
